Accordingly, we evaluated LPA responses in subjects with and without latent or active TB in a cohort of HIV-infected BCG-immunized subjects with CD4 counts ≥ 200 cells/mm3 entering a TB booster vaccine trial in Tanzania [19,20]. This evidence concerns the gene CD4 and tuberculosis.